English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Endothelin-1 is a mediator of hypoxia-induced pulmonary hypertension and pulmonary arterial remodeling, and may be involved in the pathogenesis of persistent pulmonary hypertension of the newborn and bronchopulmonary dysplasia, causes of mortality and morbidity in newborn infants. Blockade of the endothelin-A receptor was earlier shown to attenuate hypoxia-induced pulmonary hypertension and in this study, was also shown to prevent and partially reverse hypoxia-induced pulmonary vascular remodeling induced by chronic hypoxia in a newborn mouse model. These results indicate that endothelin-A receptor blockade is of potential therapeutic significance in neonates with pulmonary hypertension and abnormal pulmonary arterial remodeling.

Endothelin-A Receptor Blockade Inhibits the Effects of Hypoxia on the Newborn Lung Vasculature